{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:10:57Z","timestamp":1773911457342,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,8,7]],"date-time":"2009-08-07T00:00:00Z","timestamp":1249603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s10067-009-1240-x","type":"journal-article","created":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T20:38:01Z","timestamp":1249504681000},"page":"1301-1307","source":"Crossref","is-referenced-by-count":15,"title":["Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population"],"prefix":"10.1007","volume":"28","author":[{"given":"Lian Hong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai Feng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Xian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian Hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,7]]},"reference":[{"key":"1240_CR1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630\u2013640","journal-title":"Arthritis Rheum"},{"key":"1240_CR2","first-page":"1934","volume":"31","author":"AG Uribe","year":"2004","unstructured":"Uribe AG, Vila LM, McGwin G Jr, Sanchez ML, Reveille JD, Alarcon GS (2004) The systemic lupus activity measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol 31:1934\u20131940","journal-title":"J Rheumatol"},{"key":"1240_CR3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1191\/096120301701549688","volume":"10","author":"AM Jacobi","year":"2001","unstructured":"Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F (2001) Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 10:554\u2013561","journal-title":"Lupus"},{"key":"1240_CR4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1191\/0961203306lu2302oa","volume":"15","author":"R Prasad","year":"2006","unstructured":"Prasad R, Ibanez D, Gladman D, Urowitz M (2006) Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus. Lupus 15:285\u2013291","journal-title":"Lupus"},{"key":"1240_CR5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1191\/0961203304lu1080oa","volume":"13","author":"M Ramos-Casals","year":"2004","unstructured":"Ramos-Casals M, Campoamor MT, Chamorro A, Salvador G, Segura S, Botero JC, Yague J, Cervera R, Ingelmo M, Font J (2004) Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Lupus 13:777\u2013783","journal-title":"Lupus"},{"key":"1240_CR6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1191\/0961203303lu1015oa","volume":"13","author":"JD Reveille","year":"2004","unstructured":"Reveille JD (2004) Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 13:290\u2013297","journal-title":"Lupus"},{"key":"1240_CR7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/rheumatology\/keg078","volume":"42","author":"CS Yee","year":"2003","unstructured":"Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C (2003) Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford) 42:276\u2013279","journal-title":"Rheumatology (Oxford)"},{"key":"1240_CR8","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/rheumatology\/kem153","volume":"46","author":"AM Bertoli","year":"2007","unstructured":"Bertoli AM, Vila LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcon GS (2007) Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual. Rheumatology (Oxford) 46:1471\u20131476","journal-title":"Rheumatology (Oxford)"},{"key":"1240_CR9","first-page":"2150","volume":"32","author":"LM Vila","year":"2005","unstructured":"Vila LM, Alarcon GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD (2005) Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 32:2150\u20132155","journal-title":"J Rheumatol"},{"key":"1240_CR10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/art.22224","volume":"55","author":"LM Vila","year":"2006","unstructured":"Vila LM, Alarcon GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD (2006) Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 55:799\u2013806","journal-title":"Arthritis Rheum"},{"key":"1240_CR11","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.3899\/jrheum.080175","volume":"35","author":"AM Bertoli","year":"2008","unstructured":"Bertoli AM, Vila LM, Reveille JD, Alarcon GS (2008) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage. J Rheumatol 35:2355\u20132358","journal-title":"J Rheumatol"},{"key":"1240_CR12","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"1240_CR13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/rheumatology\/keh625","volume":"44","author":"I Hayakawa","year":"2005","unstructured":"Hayakawa I, Hasegawa M, Matsushita T, Yanaba K, Kodera M, Komura K, Takehara K, Sato S (2005) Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis. Rheumatology (Oxford) 44:873\u2013878","journal-title":"Rheumatology (Oxford)"},{"key":"1240_CR14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2230.2007.02669.x","volume":"33","author":"O Wu","year":"2008","unstructured":"Wu O, Liu HH, Li WX, Zhang N, Wang Q, Li XP, Dong MX, Zhang XJ, Ye DQ (2008) Serum soluble nucleosome and the broad family of antinucleosome antibodies are associated with organ and tissue damage in systemic lupus erythematosus in a Chinese population. Clin Exp Dermatol 33:160\u2013163","journal-title":"Clin Exp Dermatol"},{"key":"1240_CR15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/art.1780340802","volume":"34","author":"M Petri","year":"1991","unstructured":"Petri M, Genovese M, Engle E, Hochberg M (1991) Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 34:937\u2013944","journal-title":"Arthritis Rheum"},{"key":"1240_CR16","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/art.1780361011","volume":"36","author":"MB Urowitz","year":"1993","unstructured":"Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J (1993) Lupus and pregnancy studies. Arthritis Rheum 36:1392\u20131397","journal-title":"Arthritis Rheum"},{"key":"1240_CR17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jcp.53.6.424","volume":"53","author":"W Egner","year":"2000","unstructured":"Egner W (2000) The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 53:424\u2013432","journal-title":"J Clin Pathol"},{"key":"1240_CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/096120339500400202","volume":"4","author":"PE Spronk","year":"1995","unstructured":"Spronk PE, Limburg PC, Kallenberg CG (1995) Serological markers of disease activity in systemic lupus erythematosus. Lupus 4:86\u201394","journal-title":"Lupus"},{"key":"1240_CR19","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/ard.47.11.918","volume":"47","author":"ML Boey","year":"1988","unstructured":"Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM (1988) Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 47:918\u2013923","journal-title":"Ann Rheum Dis"},{"key":"1240_CR20","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/art.1780351013","volume":"35","author":"RM Hoet","year":"1992","unstructured":"Hoet RM, Koornneef I, de Rooij DJ, van de Putte LB, van Venrooij WJ (1992) Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum 35:1202\u20131210","journal-title":"Arthritis Rheum"},{"key":"1240_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/096120339500400113","volume":"4","author":"M Satoh","year":"1995","unstructured":"Satoh M, Yamagata H, Watanabe F, Nakayama S, Ogasawara T, Tojo T, Akizuki M (1995) Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in an elderly woman with long-standing Sjogren\u2019s syndrome. Lupus 4:63\u201365","journal-title":"Lupus"},{"key":"1240_CR22","first-page":"469","volume":"17","author":"M Yasuma","year":"1990","unstructured":"Yasuma M, Takasaki Y, Matsumoto K, Kodama A, Hashimoto H, Hirose S (1990) Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. J Rheumatol 17:469\u2013475","journal-title":"J Rheumatol"},{"key":"1240_CR23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-3083.2006.01819.x","volume":"64","author":"BT Kurien","year":"2006","unstructured":"Kurien BT, Scofield RH (2006) Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol 64:227\u2013235","journal-title":"Scand J Immunol"},{"key":"1240_CR24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1191\/0961203303lu430oa","volume":"12","author":"HI Brunner","year":"2003","unstructured":"Brunner HI, Jones OY, Lovell DJ, Johnson AM, Alexander P, Klein-Gitelman MS (2003) Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage. Lupus 12:600\u2013606","journal-title":"Lupus"},{"key":"1240_CR25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1529-0131(200104)45:2<191::AID-ANR173>3.0.CO;2-2","volume":"45","author":"GS Alarcon","year":"2001","unstructured":"Alarcon GS, McGwin G Jr, Bastian HM, Roseman J, Lisse J, Fessler BJ, Friedman AW, Reveille JD (2001) Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 45:191\u2013202","journal-title":"Arthritis Rheum"},{"key":"1240_CR26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.03280807","volume":"3","author":"YE Chen","year":"2008","unstructured":"Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ (2008) Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol 3:46\u201353","journal-title":"Clin J Am Soc Nephrol"},{"key":"1240_CR27","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0272-6386(00)70262-9","volume":"35","author":"SM Korbet","year":"2000","unstructured":"Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD (2000) Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35:904\u2013914","journal-title":"Am J Kidney Dis"},{"key":"1240_CR28","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/0961203308093458","volume":"17","author":"S Duran-Barragan","year":"2008","unstructured":"Duran-Barragan S, Ruvalcaba-Naranjo H, Rodriguez-Gutierrez L, Solano-Moreno H, Hernandez-Rios G, Sanchez-Ortiz A, Ramos-Remus C (2008) Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus. Lupus 17:1117\u20131121","journal-title":"Lupus"},{"key":"1240_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3949\/ccjm.76a.gr005","volume":"76","author":"S Manzi","year":"2009","unstructured":"Manzi S (2009) Lupus update: perspective and clinical pearls. Cleve Clin J Med 76:137\u2013142","journal-title":"Cleve Clin J Med"},{"key":"1240_CR30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2008.08.004","volume":"8","author":"S Sitia","year":"2009","unstructured":"Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, Antonini-Canterin F, Di Salvo G, De Gennaro Colonna V, La Carrubba S et al (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8:281\u2013286","journal-title":"Autoimmun Rev"},{"key":"1240_CR31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1191\/096120399680411443","volume":"8","author":"JD FitzGerald","year":"1999","unstructured":"FitzGerald JD, Grossman JM (1999) Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients. Lupus 8:638\u2013644","journal-title":"Lupus"},{"key":"1240_CR32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1191\/096120300678828433","volume":"9","author":"J Thumboo","year":"2000","unstructured":"Thumboo J, Lee HY, Fong KY, Chan SP, Chapman CA, Leong KH, Feng PH, Thio ST, Boey ML (2000) Accuracy of medical record scoring of the SLICC\/ACR damage index for systemic lupus erythematosus. Lupus 9:358\u2013362","journal-title":"Lupus"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1240-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-009-1240-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1240-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:36Z","timestamp":1559105496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-009-1240-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,7]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1007\/s10067-009-1240-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,7]]}}}